TrialNature communications2024

Identifying key circulating tumor DNA parameters for predicting clinical outcomes in metastatic non-squamous non-small cell lung cancer after first-line chemoimmunotherapy.

Haolun Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.